PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹4,850 Cr | ₹4,842 Cr | ₹4,175 Cr | ₹3,903 Cr | ₹3,854 Cr |
What is the latest Total Liabilities ratio of PFIZER ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹4,850 Cr |
| Mar2025 | ₹4,842 Cr |
| Mar2024 | ₹4,175 Cr |
| Mar2023 | ₹3,903 Cr |
| Mar2022 | ₹3,854 Cr |
How is Total Liabilities of PFIZER Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,850 Cr | 0.16 | |
| Mar2025 | ₹4,842 Cr | 15.98 | |
| Mar2024 | ₹4,175 Cr | 6.96 | |
| Mar2023 | ₹3,903 Cr | 1.29 | |
| Mar2022 | ₹3,854 Cr | - | |
Compare Total Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹20,877.6 Cr | -3.7% | 1.5% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -3.7% |
1.5% |
-14.4% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses